Surgery Partners, Inc. SGRY Sales of and distributions from equity method investments

Sales of and distributions from equity method investments at other companies

VestisVSTS

$0—

Devon EnergyDVN

$9M0.0%

Hewlett Packard EnterpriseHPE

$0-100%

GE VernovaGEV

$44M-51.1%

Devon EnergyDVN

$9M0.0%

Williams CompaniesWMB

$40.25M—

Other financials

Income statement

See full

Revenue$810.9M+4.5%

Operating income$65.8M+6.3%

Net income-$35.9M+4.8%

EPS (diluted)-$0.28+6.7%

Balance sheet

See full

Cash & equivalents$182.3M-20.5%

Total debt$5.1B+4.6%

Total equity$1.7B-3.0%

Total assets$8.0B+1.2%

Cash flow

See full

Operating cash flow$11.7M+95.0%

CapEx$16.0M-29.5%

Free cash flow-$4.3M+74.3%

Valuation

See full

Market cap$1.99B-49.1%

Profitability

See full

Gross margin23.1%—

Operating margin11.8%+1.2pp

Net margin-2.3%-0.9pp

FCF margin6.2%+0.8pp

Returns & leverage

See full

Return on equity-4.4%-1.6pp

Debt / equity3×+0.2×

Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfEquityMethodInvestments.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s sales of and distributions from equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Surgery Partners, Inc.'s sales of and distributions from equity method investments?: Surgery Partners, Inc. (SGRY) reported sales of and distributions from equity method investments of $900K in Q1 2026.
What is the long-term trend for Surgery Partners, Inc.'s sales of and distributions from equity method investments?: Over 2 years (2021 to 2025), Surgery Partners, Inc.'s sales of and distributions from equity method investments has grown at a -47.3% compound annual growth rate (CAGR), from $5.4M to $1.5M.